Package 61919-558-90

{"route": ["ORAL"], "spl_id": "4c4a1599-23d9-4beb-e063-6294a90a2c6b", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["116cc898-66d6-e3a9-e063-6294a90a67fb"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-558-60)", "package_ndc": "61919-558-60", "marketing_start_date": "20240215"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-558-72)", "package_ndc": "61919-558-72", "marketing_start_date": "20240215"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-558-90)", "package_ndc": "61919-558-90", "marketing_start_date": "20240215"}], "brand_name": "Bupropion HCL ER (XL)", "product_id": "61919-558_4c4a1599-23d9-4beb-e063-6294a90a2c6b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "61919-558", "generic_name": "Bupropion HCL ER (XL)", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion HCL ER (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20240215", "listing_expiration_date": "20271231"}